Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
The radiotherapy treatment comes from an electrical machine called a ‘Linear accelerator’ and is directed as a beam to the part of the body that needs to be treated. Treatment is given daily over a period of days or weeks and you may hear people call these treatments ‘fractions’. They are just a fraction of your treatment dose and plan.
Chemotherapy at the Rutherford takes place in our modern therapy suites, consisting of up to ten treatment areas offering treatment for haematology/oncology patients requiring systemic anti-cancer therapy (SACT) and supportive care in an outpatient setting. The infusion therapy suites are available for patients undergoing treatment for breast, urology, upper and lower gastrointestinal cancers, and both malignant and non-malignant haematology disorders.
Rutherford Diagnostics is going to revolutionise healthcare across the globe utilising genomic sequencing, personalised screening and innovative diagnostic technologies.
Rutherford Diagnostics is going to deliver a new healthcare paradigm supporting best possible healthcare outcomes through prediction, prevention and earliest possible detection of disease.
By utilising and developing innovative technologies, such as genomic sequencing, personalised screening and state-of-the-art diagnostics to reduce levels of acute illness and support good health, Rutherford Diagnostics will revolutionise healthcare.